GlassScriptPhysician profile
Caroline Kim
NPI 1457595530
$13,137.68
in general payments reported to CMS, 2019-2025
30 companies · $55.02 in 2025
The $55.02 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $4,632 · 2021: $4,558 · 2022: $1,718 · 2023: $578 · 2024: $356 · 2025: $55.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,761.83 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $607.30 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $301.52 | 2020-2025 | Phasix Mesh |
| Mayne Pharma Commercial LLC | $204.83 | 2022-2023 | |
| Integra Lifesciences Corporation | $200.49 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $125.76 | 2021 | |
| Kci USA, INC. | $122.82 | 2019 | |
| Acell, INC. | $104.72 | 2020 | |
| Exeltis, USA INC. | $71.70 | 2021-2023 | Slynd |
| Avion Pharmaceuticals | $68.01 | 2023 | Balcoltra, NP Thyroid 60 |
| Alafair Biosciences, INC. | $55.31 | 2023-2024 | Versawrap |
| Conmed Corporation | $50.00 | 2019 | |
| Heron Therapeutics, INC. | $44.39 | 2021-2022 | |
| Hologic Sales and Service, LLC | $43.66 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Myovant Sciences INC. | $41.31 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $38.62 | 2022 | |
| W. L. Gore & Associates, INC. | $32.60 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Evofem Biosciences, INC. | $29.21 | 2023 | Phexxi |
| Agile Therapeutics, INC. | $26.05 | 2021-2022 | |
| Teleflex LLC | $22.48 | 2024 | Quikclot |
| Mycovia Pharmaceuticals, INC. | $21.95 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.69 | 2024 | Zilretta, Iovera, Exparel |
| Mylan Pharmaceuticals INC. | $21.03 | 2022 | |
| Dilon Technologies, INC. | $21.00 | 2023 | Hemoblast Bellows |
| Biogen, INC. | $20.31 | 2024 | |
| Aroa Biosurgery Incorporated | $18.83 | 2024 | |
| Exact Sciences Corporation | $17.06 | 2025 | Cologuard Collection Kit |
| Organogenesis INC. | $16.42 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.68 | 2023 | Quviviq |
| Novo Nordisk INC | $13.10 | 2023 | Saxenda, Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.